NCT00106717

Brief Summary

Narrative medicine addresses the therapeutic benefits that derive from patients forming and telling their personal stories. It offers an innovative model for improving health outcomes. When a patient with cancer and marked suffering writes a narrative of what he or she is going through, this process may reduce pain and improve quality of life. Therefore, we seek to evaluate the effectiveness of writing a narrative on pain intensity and health related quality of life. We propose a randomized single blind (evaluator) controlled trial. Patients with cancer pain of intensity at least 5/10 with a minimum Karnofsky score of 50% will be randomized into three groups: 1. Narrative group. Patients will write a story about their illness for at least 20 minutes once a week for 3 weeks; 2. Writing-control group. Patients will fill a pain diary once a week for three weeks; 3. Control group. Subjects will not write/fill anything. Pain will be evaluated using the numerical scale before randomization and then weekly for 8 weeks. We will also evaluate how pain interferes with general activity, mood, work, relation with others, sleep, and enjoyment of life using the Brief Pain Inventory. As secondary outcomes, we will evaluate health related quality of life, with the treatment outcomes of pain survey, which is a modification of the SF 36 (short form health survey), and a global measure of well-being before randomization, and then at 4 and 8 weeks. We will also evaluate the emotional disclosure of the narratives. We will use an intention to treat analysis. To analyze the effect of the treatment on pain intensity, quality of life, and well-being, we will employ an analysis of repeated measures using generalized estimating equations. We will include in the regression models the treatment group, the emotional disclosure score, the time, and the interaction between treatment group and time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Jan 2004

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 30, 2005

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2006

Completed
Last Updated

March 20, 2008

Status Verified

March 1, 2005

First QC Date

March 29, 2005

Last Update Submit

March 19, 2008

Conditions

Keywords

Cancer painQuality of lifeNarrative medicinePain relief

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

Secondary Outcomes (2)

  • Pain interference with general activity, mood, work, relation with others, sleep, and enjoyment of life.

  • Health related quality of life

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with cancer pain of intensity at least 5/10 with a minimum Karnofsky score of 50%

You may not qualify if:

  • Patients unable to write or read

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Ignacio Hospital

Bogotá, DC, Colombia

Location

MeSH Terms

Conditions

NeoplasmsCancer PainNarrative Medicine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNarrationCommunicationBehavior

Study Officials

  • M. Soledad Cepeda, MD, PhD

    Javeriana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 29, 2005

First Posted

March 30, 2005

Study Start

January 1, 2004

Study Completion

August 1, 2006

Last Updated

March 20, 2008

Record last verified: 2005-03

Locations